These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36896517)

  • 41. A Comparative Analysis of Statistical Methods to Estimate the Reproduction Number in Emerging Epidemics, With Implications for the Current Coronavirus Disease 2019 (COVID-19) Pandemic.
    O'Driscoll M; Harry C; Donnelly CA; Cori A; Dorigatti I
    Clin Infect Dis; 2021 Jul; 73(1):e215-e223. PubMed ID: 33079987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptive Susceptible-Infectious-Removed Model for Continuous Estimation of the COVID-19 Infection Rate and Reproduction Number in the United States: Modeling Study.
    Shapiro MB; Karim F; Muscioni G; Augustine AS
    J Med Internet Res; 2021 Apr; 23(4):e24389. PubMed ID: 33755577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mathematical investigation of an "SVEIR" epidemic model for the measles transmission.
    Hajji ME; Albargi AH
    Math Biosci Eng; 2022 Jan; 19(3):2853-2875. PubMed ID: 35240810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive model with analysis of the initial spread of COVID-19 in India.
    Ghosh S
    Int J Med Inform; 2020 Nov; 143():104262. PubMed ID: 32911257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transmission dynamics and control of COVID-19 in Chile, March-October, 2020.
    Tariq A; Undurraga EA; Laborde CC; Vogt-Geisse K; Luo R; Rothenberg R; Chowell G
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009070. PubMed ID: 33481804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multi-strain epidemic model for COVID-19 with infected and asymptomatic cases: Application to French data.
    Massard M; Eftimie R; Perasso A; Saussereau B
    J Theor Biol; 2022 Jul; 545():111117. PubMed ID: 35513167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis of the development trend and severity of the COVID-19 panidemic in the global world].
    Huang B; Wang HY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):536-542. PubMed ID: 34145857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Filtering and improved Uncertainty Quantification in the dynamic estimation of effective reproduction numbers.
    Capistrán MA; Capella A; Christen JA
    Epidemics; 2022 Sep; 40():100624. PubMed ID: 36075125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitigating bias in estimating epidemic severity due to heterogeneity of epidemic onset and data aggregation.
    Krishnan RG; Cenci S; Bourouiba L
    Ann Epidemiol; 2022 Jan; 65():1-14. PubMed ID: 34419601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimating the basic reproduction number from noisy daily data.
    Descary MH; Froda S
    J Theor Biol; 2022 Sep; 549():111210. PubMed ID: 35788342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating effects of intervention measures on COVID-19 outbreak in Wuhan taking account of improving diagnostic capabilities using a modelling approach.
    Liang J; Yuan HY; Wu L; Pfeiffer DU
    BMC Infect Dis; 2021 May; 21(1):424. PubMed ID: 33952194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends of 2019-nCoV in South Asian countries and prediction of the epidemic peaks.
    Malek A; Hoque A
    Virus Res; 2021 Jan; 292():198230. PubMed ID: 33197471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of COVID-19 epidemic curtailment strategies in selected Indian states: An analysis by reproduction number and doubling time with incidence modelling.
    Mitra A; Pakhare AP; Roy A; Joshi A
    PLoS One; 2020; 15(9):e0239026. PubMed ID: 32936811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fitting and predicting trend of COVID-19 by SVEPIUHDR dynamic model].
    Chen JL; Jin ML; Wang X; Yang XJ; Zhang N; Liu FN; Liu R; Guo JP; Chen Y; Wang CJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1341-1346. PubMed ID: 34814551
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effectiveness of precise prevention and control strategies of dynamic zero COVID-19 in Ningbo, Zhejiang province].
    Hong H; Fang T; Yi B; Xu GZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):669-673. PubMed ID: 35589570
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproduction Factor Based Latent Epidemic Model Inference: A Data-Driven Approach Using COVID-19 Datasets.
    Ahn S; Kwon M
    IEEE J Biomed Health Inform; 2023 Mar; 27(3):1259-1270. PubMed ID: 36215342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority.
    Rackimuthu S; Hasan MM; Bardhan M; Essar MY
    Int J Health Plann Manage; 2022 May; 37(3):1847-1850. PubMed ID: 34510541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategies comparison in response to the two waves of COVID-19 in the United States and India.
    Yang J; Shi L; Chen H; Wang X; Jiao J; Yang M; Liu M; Sun G
    Int J Equity Health; 2022 Apr; 21(1):57. PubMed ID: 35488277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.